Yahoo Finance

GSK's (GSK) Boostrix Gets FDA Nod for Pertussis in Newborns

GSK plc GSK announced that the FDA expanded Boostrix’s label for immunization during pregnancy to help prevent pertussis (whooping cough) in infants not older than two months. Following the label ...
FiercePharma

GlaxoSmithKline Receives FDA Approval for BOOSTRIX® to Help Prevent Whooping Cough in Adults 65 Years and Older

NEW YORK, July 8, 2011 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved BOOSTRIX® [Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine, Adsorbed (Tdap)] ...
Monthly Prescribing Reference

Boostrix vaccine approved for adults

BOOSTRIX (Tetanus and reduced diphtheria toxoid, acellular pertussis vaccine) by GlaxoSmithKline GlaxoSmithKline's combination vaccine Boostrix (tetanus toxoid, reduced diphtheria toxoid, and ...
FierceBiotech

FDA Approves GlaxoSmithKline Tetanus, Diphtheria, Whooping Cough Vaccine, BOOSTRIX(R), for Adults

PHILADELPHIA, PA -- Dec 8, 2008 -- GlaxoSmithKline (NYSE:GSK - News) announced today that the U.S. Food and Drug Administration (FDA) has approved BOOSTRIX® [Tetanus Toxoid, Reduced Diphtheria Toxoid, ...
PMLiVE

GSK’s Boostrix approved by FDA for use during pregnancy to prevent whooping cough in infants

4.2% of the cases of pertussis reported in the US in 2021 were in infants younger than six months GSK’s Boostrix (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed ...
Monthly Prescribing Reference

Boostrix Approved for Use During Pregnancy to Prevent Pertussis in Infants

Portrait of young happy pregnant woman standing by the window Effectiveness in preventing pertussis among infants younger than 2 months of age when administered during the third trimester of pregnancy ...
EurekAlert!

FDA approves Boostrix® a new US vaccine for adolescents against pertussis

PHILADELPHIA, PA, May 3, 2005 – GlaxoSmithKline (NYSE: GSK) today announced that its booster vaccine, Boostrix® [Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed ...
PharmaTimes

FDA panel to decide on Boostrix and Adacel vaccines

The US Food and Drug Administration appears comfortable with the safety and efficacy profiles presented in filings for GlaxoSmithKline and Sanofi Pasteur’s diphtheria, tetanus and whooping cough ...
Medscape

FDA Approvals: Synthetic Conjugated Estrogens-A Vaginal Cream and Boostrix

To earn CME related to this news article, click here. December 15, 2008 — The US Food and Drug Administration (FDA) has approved synthetic conjugated estrogens-A vaginal cream for the treatment of ...
pharmaphorum

GSK's Boostrix for pertussis cleared by FDA for use in pregnancy

The FDA has approved use of GlaxoSmithKline’s Boostrix (Tdap) vaccine for use during the third trimester of pregnancy, for prevention of pertussis (whooping cough) in infants younger than two months ...
Medscape

FDA Approves Expanded Age Indication for Tdap Booster Vaccine

April 20, 2009 — The tetanus toxoid/reduced diphtheria toxoid/acellular pertussis single-dose booster vaccine (Tdap; Boostrix, GlaxoSmithKline Biologicals) was approved for an expanded age indication ...